Seaweeds have proved to be exceptional resources of nutrients and secondary metabolites. The present study was designed to evaluate the antioxidant, hypoglycaemic and antidiabetic activities of some seaweeds of east coast of India namely Gracilaria verrucosa, Enteromorpha compressa, Ulva fasciata and Turbinaria conoides. Petroleum ether, ethyl acetate and methanol extracts of these seaweeds were evaluated for antioxidant activity by means of assays like total phenolic content, total reducing power, Nitric Oxide and H 2 O 2 scavenging tests. The extracts with superior antioxidant activity among these seaweeds were further tested for hypoglycaemic and antidiabetic activity. Ethyl acetate extract of Ulva fasciata (EAU) has shown promising results after all these tests. IC 50 value of EAU was found to be 123.39 and 127.65ìg/ml for H 2 O 2 and NO free radical scavenging activity respectively. Total phenol content for EAU was 207.23 ± 2.41mg/g. Fasting plasma glucose level in normal mice was significantly (p<0.05) decreased even after 6 days of EAU treatment at the dose 200mg/kg. The area under curve of oral glucose tolerance test was not affected significantly, though considerable reduction in AUC was found in both EAU 100 and 200 mg/kg treated groups. It was found that EAU has potent in vitro alpha-amylase inhibiting property when compared to the standard, Acarbose. The current findings suggest that, the antidiabetic activity of U. fasciata may be due to its underlying antioxidant, hypoglycemic and alpha amylase inhibiting property. Hence, this seaweed can be beneficial for diabetic individuals.
INTRODUCTION
Diabetes mellitus is a cluster of neverending diseases, which is recognized by its most common characteristic, hyperglycaemia. It is usually classified in to two main categories i.e. Type I diabetes mellitus (T 1 DM), caused due to complete absence of insulin production and Type II diabetes mellitus (T 2 DM), due to the relative deficiency of insulin secretion and tissue resistant to the insulin action 1 . Majority of this disease all over the world may be correlated to modern diet, obesity and modern sedentary lifestyle. The mortality associated with diabetes is mainly due to the increased risk of several complications of this disease. Very often the most common life threatening complications includes hypertension, retinopathy, nephropathy and other cardio vascular diseases 2 . These incidences necessitate and warrant the search for new preventive measures as well as healing strategy of this disease.
Traditionally, several seaweeds have been consumed as food in many parts of the world especially among Asian coastal communities. According to some report, Japanese consume approximately 5.3 g seaweed in their daily diet 3 . In addition to this, seaweed has also been reported to be used against numerous disease causing ailments in different Asian traditional medical systems 4 . Some studies have revealed that, regular consumption of seaweed lowers menace of several diseases like cardiovascular disease, hyperlipidaemia and breast cancer 5, 6 . Furthermore some studies have also established the fact that, reduction of seaweed consumption in some Asian societies that regularly used to consume seaweed due to an enhanced yearning for Westernised diet, augmented occurrence of unending lifestyle diseases 6 . These studies highlight the promising health benefits offered by seaweed. It's true that despite of these proven facts, this generous treasure of the ocean has been ignored since long. Even today they are the same under-utilised and untapped resources of diversified secondary bio molecules having potential therapeutic applications, normally absent in terrestrial plants.
In this study, we aim to communicate the beneficial utility of some seaweed obtained from Indian east coast in preventing and managing diabetes via various pharmacologically relevant attestations. Seaweed flora is represented by three major classes' namely green, brown and red algae which differ from one another in their morphology, life cycle, distribution, pigment and secondary metabolite composition. It was decided by us to take one or two species from each class to assess their antidiabetic potential. During the course of study one species of red algae Gracilaria verrucosa (Huds.) Papenfuss (Family: Gracilariaceae), two species of green algae Eenteromorpha compressa (L.) Grev. (Family: Ulvaceae) and Ulva fasciata Delile (Family: Ulvaceae) were collected from the Chilika Lake, Odisha, Indian east coast. Due to nonavailability of brown seaweed along the Odisha coast, one of the species from this variety Turbinaria conoides (J. Agardh) Kutzing (Family: Sargassaceae) was obtained from the Palk Bay and Gulf of Mannar, Tamilnadu, Indian east coast. All seaweeds were properly identified and authenticated by Prof. R.C. Panigrahy, marine taxonomist, Berhampur University, Berhampur, Odisha, India.
From some of the studies it is confirmed that a sufficient use of antioxidant may prevent or delay â-cells dysfunction in diabetes and prevent the development of complications associated with this disease 7, 8 . Hence, initially all of these seaweed extracts were investigated for their probable antioxidant property. Those extracts showing good results in this preliminary investigation, were further evaluated for their in vivo hypoglycaemic and antidiabetic properties in normal and diabetes induced animals respectively.
MATERIALS AND METHODS

Materials
Only analytical grade chemicals were used for this investigation. Streptozotocin (STZ), Ethylene diamine tetra acetic acid (EDTA) and haematoxylin-eosin (H&E) dye were purchased from Himedia Lab. and Loba Chemie Pvt. Ltd., India. All other solvents and chemicals were procured from Merck Specialties Pvt. Ltd., India. Biochemical parameters were investigated by using glucose kit (GOD/POD method), triglycerides kit (GPO/PAP method) and cholesterol kit (CHOD/PAP method) which were obtained from Crest Biosystems, India.
Seaweed extraction
Seaweeds collected from different places were carefully washed with sea water and subsequently in distilled water to get rid of all debris and impurities. These seaweeds were then air dried and stored in air tight polyethylene bags for further use. Required amount of each of the seaweed was cut into small pieces with the help of sharp knife and powdered with the help of electronic grinder separately. These powders were sieved by using No.16 mesh. Exactly, 1000g of each seaweed powder was extracted separately in soxhlet apparatus in the increasing order of polarity using three solvents i.e petroleum ether (pet. ether), ethyl acetate and methanol 9, 10 . 
Phytochemical analysis of extracts
The extracts obtained were analyzed for presence of different phytoconstituents using established validated qualitative methods 9, 10 .
In vitro antioxidant evaluation of extracts
The antioxidant property of each extract was evaluated following the standard methods described below. The chemical tests were performed in triplicate for each seaweed extract.
Determination of total phenol content
Total phenolic content was determined by Folin-ciocalteu reagent method using Gallic acid as the standard for phenolic compound 11 . In this method, initially 5 ml of the reagent was mixed with 1 ml of Gallic acid at different concentrations (50, 100, 150, 200 ìg/mL) and to which 4 ml of 2% Sodium carbonate was added after 3 minutes. Thirty minutes later, the absorbance of the blue colour was measured at 760 nm. The concentrations of total phenols were expressed as mg/g of dry extract 12 .
Total reducing power
The seaweed extracts (50, 100, 150 and 200 ìg/ml) prepared in distilled water and 1% potassium ferric cyanide were mixed with phosphate buffer (0.2 M, pH 6.6) and incubated at 50°C for 20 min. Then, 2.5 ml of 10% TCA was added to this reaction mixture and centrifuged at 1000 × g for 10 min. The upper layer of the solution (2.5 ml) was mixed with 2.5 ml of distilled water and FeCl 3 (0.5 mL, 0.1%). The absorbance was measured at 700 nm. BHT (50 to 200ìg/ml) was used as positive control. The higher the absorbance of the reaction mixture, the greater is its reducing power. Total reducing capacity of seaweed extracts was determined adopting a most widely used method 13 .
Nitric oxide radical scavenging activity
In this test, 3 ml of the reaction mixture containing 10 mM sodium nitroprusside and different seaweed extracts (50, 100, 150, 200 ìg/ ml) in phosphate buffer were incubated at 25°Cfor 150 min. Then, 0.5 ml of each incubated reaction mixture was mixed with 1 ml of sulfanilic acid reagent (0.33% in 20% glacial acetic acid) and allowed to stand for 5 min for complete diazotization. Then 1 ml of naphthyl ethylene diamine dihydrochloride (0.1%) was added and the solution was mixed thoroughly. The mixture was allowed to stand for 30 min at 25°C.A pink colored chromophore is formed in diffused light. The absorbance of pink colour solution was measured at 540nm against the corresponding blank solutions. BHT (50-200ìg/ml) was used as positive control. 
In vivo hypoglycaemic and antidiabetic study Experimental animals
Animal experiments were designed and conducted in accordance with the policies of committee for the purpose of control and supervision of experiments in animal (CPCSEA), India. The experimental protocol was approved (no. 66, dated 7/06/2012) by institutional animal ethics committee (IAEC), Roland Institute of Pharmaceutical Sciences, Berhampur, Odisha, India. Swiss albino mice (22-27 g) were housed in standard cages (48×35×22 cm) at room temperature (20 ± 2°C), relative humidity (55-60%) and a 12 h light/dark cycle. They were fed with normal chow pellet, and water ad libitum.
Toxicity study
The extracts i.e. EAU, EAT and EAG were selected based on their potential antioxidant activity. The extracts of the seaweed Enteromorpha compressa were excluded from further in vivo evaluation due to their poor antioxidant property. Toxicity study of these selected extracts on female Swiss albino mice was carried out as per OECD regulations 423 16 . The highest dose (i.e. 2000 mg/ kg) of each extract was administered orally to the overnight fasted mice. The signs of possible toxicity were observed at every 3 hours for the first 24 hours and every day for 14 days. Individual animal weight was noted down daily and any signs or symptoms of toxicity and mortality was observed for 14 days as described in previous studies 17 .
Hypoglycemic activity in normal mice
Animals were grouped as follow and administered the respective treatment intraperitoneally (i.p.). Group 1: 1% sodium CMC; Group 2: EAU (200 mg/kg); Group 3: EAT (200 mg/ kg) and Group 4: EAG (200 mg/kg). Each group consists of five animals. Animals were fasted overnight for a period of 12 h. After the single i.p. injection of the respective extracts, blood sample (0.1 ml) was collected in micro tubes previously filled with 10% EDTA solution (20 ìl of 10% EDTA/ ml of blood). Blood was collected through retro orbital route under mild ether anesthesia at 0, 0.5, 1, 2, 4, 6, 10 and 24 h. The micro tubes were centrifuged at 4000 rpm at 4°C for 20 min to obtain clear plasma. The plasma was then analyzed for glucose in the auto analyzer (3000 Evolution, BSI Italy) using commercially available glucose estimation kits. The data is expressed as the percentage change of blood glucose obtained at different time points 18 .
Antidiabetic activity
Antidiabetic study was carried out for EAU, which showed the best hypoglycaemic activity as compared to the other extracts.
Diabetes induction and grouping of animals
Alloxan monohydrate (150 mg/kg, i.p.) was injected to the overnight fasted male Swiss albino mice 19 . Hyperglycaemia was confirmed by the elevated plasma glucose levels (>180 mg/dL) after 3 days of the induction. The diabetic mice were randomized into 5 different groups and the treatment was administered orally for six consecutive days as follows. However, one group was kept as nondiabetic control without drug treatment (Group 1); Group 2: diabetic control, 1% sodium CMC; Group 3: EAU (100 mg/kg); Group 4: EAU (200mg/kg); and Group 5: Gliclazide (GLI) (10 mg/kg). Each group consists of five animals. At the end of sixth day, blood sample was collected from the retro orbital route of each mouse and biochemical parameters such as plasma glucose, triglyceride and total cholesterol was estimated.
Oral glucose tolerance test (OGTT)
OGTT was performed in overnight (18 h) fasted mice with water ad libitum 20, 21 . On 6 th day of treatment, glucose (2 g/kg) was fed to each animal 10 min after collecting blood sample which was taken as reference (0 min). Exactly 0.1 mL of blood was withdrawn from the retro orbital route of each mouse under mild ether anaesthesia at 30, 60 and 120 min after the glucose load. The blood samples were centrifuged to obtain clear plasma which was then analyzed for glucose by using commercially available biochemical kits.
In vitro α α α α α-amylase enzyme inhibition assay
The α-amylase inhibition activity of EAU was determined by following a established method 22 . Starch azure (2mg) was suspended in each of tubes containing 0.2ml of 0.5M Tris-HCL buffer (pH 6.9) and 0.01M CaCl 2 . The tubes containing substrate solution were boiled for 5 min and were then incubated at 37R"C for 5 min. Seaweed extract (0.2ml) was taken in each tube containing different concentrations (20, 40, 60, 80 and 100 µg/ml). Porcine Pancreatic amylase (PPA) was dissolved in Tris-HCL buffer to form a concentration of 2units/ml and 0.1ml of this enzyme solution were added to each of the above mentioned tubes. The reaction was carried out at 37R"C for 10 min and was stopped by adding 0.5ml of 50% acetic acid in each tube. The reaction mixture was centrifuged at 3000 rpm for 5 min at 4R"C. The absorbance of the resulting supernatant was measured at 595 nm. The α-amylase inhibition activity was calculated as follows: 
Statistical analysis
Results were expressed as mean ± SEM. Data were analyzed with One-way Analysis of Variance (ANOVA), followed by Tukey's multiple comparison tests. The level of significance was set at p< 0.05.
RESULTS
Preliminary phytochemical analysis of different extracts
The detail results of qualitative preliminary phytochemical assays of different seaweed extracts are illustrated in Table 1 . Presence of alkaloid was detected in PEU. Gum and mucilage was detected in two green seaweed extracts (MEU and MEE). Tannins, protein and amino acids were detected in methanol extracts of all seaweeds. Phenolic compounds were detected in ethyl acetate and methanol extracts of all seaweeds. Whereas, carbohydrate was absent in all the seaweed extracts.
In vitro antioxidant evaluation of extracts Total phenol content
The total phenol content expressed as gallic acid equivalents was found to be highest for EAU (207.23 ±2.41mg/g) compared to the other extracts as represented in Table 2 . The lowest phenol content was found in MEE (25.03 ± 4.91 mg/g). In general, phenolic compounds were found in all the three groups' i.e. brown, green and red seaweeds taken in the present study.
Total reducing power
Reducing capacity of seaweed extracts and BHT (50-200 µg/mL) is given in Figure 1 . EAU showed higher reducing ability at all concentrations compared to other seaweed extracts. At 200 µg/mL the reducing activity of EAU was found to be (absorbance, 1.18 ± 0.006), which was almost nearer to the value recorded for standard BHT (absorbance, 1.48). The reducing ability of methanol extracts of E.compressa and G. Verrucosa was found to be the lowest as compared to the other seaweed extracts. 
Toxicity study of the seaweed extracts as per OECD guidelines 423
We observed no significant toxic signs or death during the 14 day observation period. None of the mice showed clinical toxic signs such as anorexia, depression, lethargy and also no mortality happened throughout the examination.
In vivo hypoglycaemic and antidiabetic study Hypoglycaemic activity in normal mice Hypoglycaemic effect of EAU, EAT and EAG ate 200 mg/kg is presented in Figure 2 . It has been observed that EAU showed the highest hypoglycaemic effect in comparison to other seaweed extracts. Hypoglycaemic effect of seaweeds extracts follows as EAU>EAT>EAG. Maximum effect was observed in between 4 -6 h of extract administration. EAU treated mice showed -20% and -25% change in plasma glucose at 4 and 6 h respectively. The least change (-10%) in plasma glucose was observed in case of EAG treated mice at 4 h.
Plasma glucose, triglyceride and total cholesterol
Fasting plasma glucose, triglyceride and total cholesterol was estimated before and after the drug treatment. EAU (200 mg/kg) treated animals showed significant (p < 0.05) reduction in their plasma glucose level after the treatment. However, GLI (10 mg/kg) treated mice showed the maximum reduction (p < 0.01) in plasma glucose as compared to other treatment groups. Fasting plasma triglyceride level in all control and treated animals did not showed significant changes before and after treatment. Plasma total cholesterol was measured before and after the drug treatment for all the groups. EAU at 200 mg/kg showed significant (p < 0.05) reduction in total cholesterol level after treatment. The results are summarized in Table 4 .
Oral glucose tolerance test (OGTT)
The extent of reduction in AUC of OGTT was higher in Gliclazide (50 mg/kg) treated mice (p<0.01). The EAU (100 and 200 mg/kg) treated animals though showed decreased trend in the AUC as compared to the diabetic groups but, it was not found to be significant. The AUC of the plasma glucose disappearance curve is shown in Fig. 3 .
In vitro α α α α α-amylase inhibitory assay
In the present study, the results of in vitro α-amylase inhibitory assay showed that Ulva sp. exhibited a potent inhibitory activity on á-amylase enzyme (IC 50 = 69.122 µg/ml) compared with the positive standard, acarbose (IC 50 = 49.344 µg/ml) ( Table 5) . A concentration dependent inhibition was observed for various concentrations of these algal extracts. The percentage inhibitory activity for EAU was found to be 60.191 ± 2.235 (at 100µg/mL). The percentage inhibitory activity for acarbose at the same concentration was observed as 75.733 ± 0.068.
DISCUSSION
Marine macro algae are recognized as potential source of several important secondary metabolites including alkaloids, phenols, flavonoids, saponins, steroids and other related active metabolites. These secondary metabolites participate extensively in their defence against diseases, microorganism, stress and interspecies protections. They have been extensively studied for their importance in furnishing good health and defend against diseases and thus seaweeds could definitely behave as budding hypoglycemic and antidiabetic agents 23 . Therefore, priliminary phytochemical screening serves as the opening step in predicting the types of probable active compounds present in these seaweed extracts so that the best ever extracts among them could be selected for further studies. The results of the preliminary photochemical study revealed that ethyl acetate and methanol extracts of almost all the seaweeds showed the presence of some of the most important secondary metabolites like terpenoid, flavonoids and phenolics. These metabolites have been proven to provide encouraging antioxidant and anti-diabetic properties 24, 25 .
Some studies reveal the fact that ROS leads to cell and tissue dysfunction and injury caused by glucolipotoxicity in diabetes 26, 27 . In addition to that studies have also proven that, antioxidants can bring to bear valuable effects on pancreatic â-cells function in diabetes by providing security against glucose toxicity 8 . Thus, an adequate use of antioxidants may be valuable in counteracting diabetic complications and managing the disease. In this study, the extracts containing suitable metabolites (Terpenoid, flavonoids, amino acids and phenolics) were evaluated for potential antioxidant activity using established in vitro assays. The results of the present study revealed that ethyl acetate extracts of all the seaweeds exhibited considerable free radical scavenging activity. The reason behind this may be due to the presence of considerable amount of phenolics in them as some studies have claimed that there exist a positive correlation between total phenolic content and antioxidant property 28, 29 . Based on this fact, EAU, EAT and EAG were studied for hypoglycaemic effect in normal Swiss albino mice as they showed good total phenolic content and prior study has reported that phenolic components present in seaweeds exert potential hypoglycaemic effect 30 . The finding of this study leads to infer that EAU has potent hypoglycemic effect in normal mice and hence this extract was selected for further antidiabetic study as compounds with hypoglycemic principle have got more direct role in antihyperglycemic activity 31 .
